CSL - Assets

Stock Price
131.30
Daily Change
1.30 1.00%
Monthly
-6.76%
Yearly
-46.25%
Q2 Forecast
127.56

CSL reported $37.9B in Assets for its fiscal semester ending in December of 2025.





Assets Change Date
Alterity Therapeutics Limited AUD 37.98M 15.78M Dec/2025
Arca Biopharma USD 488.62M 20.63M Dec/2025
aTyr Pharma USD 515.34M 408.68M Dec/2025
Bio Path USD 690K 56K Sep/2025
Brainstorm Cell Therapeutics USD 1.02M 358K Dec/2025
Cara Therapeutics USD 39.02M 4.73M Sep/2025
CSL USD 37.9B 1.5B Dec/2025
Curis USD 19.97M 9.27M Dec/2025
Esperion Therapeutics USD 465.89M 101.87M Dec/2025
Immunic USD 40.7M 20.72M Sep/2025
Infinity Pharmaceuticals USD 21.23M 8.72M Jun/2023
Minerva Neurosciences USD 97.97M 69.88M Dec/2025
Sangamo BioSciences USD 97.56M 11.39M Jun/2025
TherapeuticsMD USD 40.13M 1.96M Jun/2024